Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Change in Receivables (2016 - 2020)

Plus Therapeutics has reported Change in Receivables over the past 11 years, most recently at -$951000.0 for Q3 2020.

  • Quarterly Change in Receivables fell 119.72% to -$951000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$951000.0 through Jun 2021, down 199.37% year-over-year, with the annual reading at -$1.2 million for FY2020, 197.17% down from the prior year.
  • Change in Receivables was -$951000.0 for Q3 2020 at Plus Therapeutics, down from -$27000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $4.8 million in Q3 2019 and troughed at -$3.6 million in Q4 2019.
  • The 5-year median for Change in Receivables is -$138000.0 (2017), against an average of -$39105.3.
  • The largest YoY upside for Change in Receivables was 11383.33% in 2019 against a maximum downside of 2451.05% in 2019.
  • A 5-year view of Change in Receivables shows it stood at $270000.0 in 2016, then plummeted by 151.11% to -$138000.0 in 2017, then dropped by 3.62% to -$143000.0 in 2018, then plummeted by 2451.05% to -$3.6 million in 2019, then soared by 73.93% to -$951000.0 in 2020.
  • Per Business Quant, the three most recent readings for PSTV's Change in Receivables are -$951000.0 (Q3 2020), -$27000.0 (Q2 2020), and -$191000.0 (Q1 2020).